Is Tesamorelin + Ipamorelin Blend safe during pregnancy or breastfeeding?

Tesamorelin + Ipamorelin Blend, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

Should I cycle Tesamorelin + Ipamorelin Blend?

Standard cycle for Tesamorelin + Ipamorelin Blend is 8–12 weeks of 1x daily subq 1 mg tesamorelin + 200 mcg ipamorelin dosing via subq, followed by a 4 week complete off-period. The off-period is calibrated to Tesamorelin + Ipamorelin Blend's Mixed half-life and to typical receptor downregulation timelines. Continuous indefinite dosing does not show additional clinical benefit in the published literature and increases cumulative downregulation risk.

Home/ Compounds/ Tesamorelin + Ipamorelin Blend

Tesamorelin + Ipamorelin Blend

Sourcing Guide

Sourcing Tesamorelin + Ipamorelin Blend from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. A potent GH-releasing blend combining tesamorelin's stabilised GHRH activity with ipamorelin's selective ghrelin-receptor agonism — synergistic with cleaner side-effect profile than higher-cortisol GHRPs. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.

Sourcing / Quality / Procurement Applications

Vendor ComparisonLot VariabilityCold ChainBAC Water SourcingCOA Review

Key Takeaways

Procurement lens: Tesamorelin + Ipamorelin Blend sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching Variable.
Mechanism: Tesamorelin engages the GHRH receptor; ipamorelin engages the GHSR.
Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days.
Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger).
Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.

Sourcing / Quality / Procurement Mechanism

For procurement of Tesamorelin + Ipamorelin Blend, the relevant QC framework covers analytical purity (HPLC), structural identity (mass spec), microbiological safety (endotoxin), and stoichiometric correctness where applicable. Tesamorelin engages the GHRH receptor; ipamorelin engages the GHSR. Pathways converge on the somatotroph for multiplicative GH release. Ipamorelin's selectivity avoids cortisol and prolactin elevation. The subsections below address each QC layer and the vendor-tier landscape.

COA evaluation and red flags

Acceptable Tesamorelin + Ipamorelin Blend certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.

Vendor tier comparison and price discipline

Three vendor tiers operate in the Tesamorelin + Ipamorelin Blend market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.

Reconstitution and storage protocols

Tesamorelin + Ipamorelin Blend is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.

Sourcing / Quality / Procurement Applications

GMP vs Research Grade

Sourcing Tesamorelin + Ipamorelin Blend for gmp vs research grade use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Vendor Comparison

Pharmaceutical-grade compounded Tesamorelin + Ipamorelin Blend is the lowest-risk sourcing path for vendor comparison use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.

Regulatory Sourcing

For users targeting regulatory sourcing, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.

Lyophilisation Quality

Sourcing Tesamorelin + Ipamorelin Blend for lyophilisation quality use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	1 mg tesamorelin + 200 mcg ipamorelin	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	1 mg tesamorelin + 200 mcg ipamorelin	4–6 weeks initial cycle
Sourcing Guide focus	SubQ	1 mg tesamorelin + 200 mcg ipamorelin	1x daily SubQ
Maintenance phase	SubQ	1 mg tesamorelin + 200 mcg ipamorelin	Ongoing with periodic pauses

Dose timing for Tesamorelin + Ipamorelin Blend is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses. Fasted dosing produces stronger GH pulses; meal-paired dosing blunts the response.

Stacking

Tesamorelin + Ipamorelin Blend stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.

Tesamorelin + Ipamorelin Blend + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Tesamorelin + Ipamorelin Blend's mechanism in sourcing / quality / procurement protocols.
Tesamorelin + Ipamorelin Blend + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Tesamorelin + Ipamorelin Blend's mechanism in sourcing / quality / procurement protocols.
Tesamorelin + Ipamorelin Blend + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with Tesamorelin + Ipamorelin Blend's mechanism in sourcing / quality / procurement protocols.
Tesamorelin + Ipamorelin Blend + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Tesamorelin + Ipamorelin Blend's mechanism in sourcing / quality / procurement protocols.

Safety & Regulatory Status

WADA: Both banned (S2) FDA: Tesamorelin alone approved; blend unapproved

Combined profiles. Monitor IGF-1.

Lens-specific safety considerations for sourcing / quality / procurement use of Tesamorelin + Ipamorelin Blend: Combined profiles. Monitor IGF-1. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Ipamorelin selectivity

PMID 9849822

Tesamorelin + Ipamorelin Blend vs Related Peptides

Compound	Profile	Onset	Best For
Tesamorelin + Ipamorelin Blend	GHRH + GHRP combination	Mixed	Sourcing Guide
BPC-157	Stable gastric pentadecapeptide	~4 hr (oral)	Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling
TB-500	Synthetic thymosin β4 fragment	~2-3 days	A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite

Frequently Asked Questions

What should I check on a Tesamorelin + Ipamorelin Blend COA?

Acceptable certificates: lot-specific (not template), HPLC purity ≥98%, mass spec confirmation matching Variable Da, endotoxin testing for injectable routes, accredited third-party lab issuance. Template COAs and missing endotoxin data are red flags.

Pharmaceutical-grade versus research-grade?

Pharmaceutical-grade is GMP-manufactured, COA-backed, prescription-dispensed material with comprehensive quality assurance. Research-grade is laboratory-purpose, COA-backed, not dispensed under prescription. Quality varies substantially between research-grade vendors; pharmaceutical-grade has a tighter quality distribution and a higher price.

Storage protocol?

Lyophilised: −20°C for 18–24 months. Reconstituted with bacteriostatic water: 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Cold-chain shipping is preferred for purchases; insulated packaging without active cooling is acceptable for shorter transit windows.

Reconstitution best practices?

Use sterile bacteriostatic water (0.9% benzyl alcohol). Inject the BAC water down the side of the vial, not directly onto the lyophilised powder. Allow gentle dissolution; do not shake vigorously — swirl the vial. Label the reconstituted vial with concentration and date.

What is the evidence base for Tesamorelin + Ipamorelin Blend?

Tesamorelin + Ipamorelin Blend's evidence base sits at research level investigational. The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The sourcing / quality / procurement interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

How does Tesamorelin + Ipamorelin Blend's half-life affect dosing?

Tesamorelin + Ipamorelin Blend has a plasma half-life of Mixed, which is moderate, supporting once-daily dosing in most protocols. The receptor occupancy curve under 1x daily subq dosing at 1 mg tesamorelin + 200 mcg ipamorelin per dose explains the typical onset timeline for sourcing and quality-control endpoints.

Clinical Protocol

Start a Tesamorelin + Ipamorelin Blend Protocol

Alukard provides GMP-certified physician-supervised sourcing with GMP-certified Tesamorelin + Ipamorelin Blend and Pharmaceutical-grade compounds with full COA documentation.

Get Protocol

Quick Facts

Molecular weight: Variable
Half-life: Mixed
WADA: Both banned (S2)
FDA: Tesamorelin alone approved; blend unapproved

Stack Partners

BPC-157

TB-500

GHK-Cu

Ipamorelin

Semax

Research Note

All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Tesamorelin + Ipamorelin Blend unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

GMP-certified physician-supervised sourcing

Start Your Sourcing / Quality / Procurement Protocol for Tesamorelin + Ipamorelin Blend

Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised